NOVOPHARM - MILLER SPÓŁKA JAWNA
UL. KS. RYSZARDA MARKWARTA 4/6, 85-015 BYDGOSZCZ
TAX ID9532515962
Rate company:
NOVOPHARM - MILLER SPÓŁKA JAWNA
TAX ID9532515962
KRS0000243158
No opinion.   Add your first review

address

UL. KS. RYSZARDA MARKWARTA 4/6, 85-015 BYDGOSZCZ

Website

www.apteka.zyj-zdrowo.com
Is this your company?Update company information to get new customers, get notified of new reviews, and more!
Dołącz do ALEO.com

Register Data

Full name

NOVOPHARM - MILLER SPÓŁKA JAWNA

Copy
uses securityreCAPTCHA

Legal address

UL. KS. RYSZARDA MARKWARTA 4/6, 85-015 BYDGOSZCZ

NIP

9532515962
Copy

REGON

340111785
Copy

KRS

0000243158
Copy

Legal form

general partnership

Register Address

UL. KS. RYSZARDA MARKWARTA 4/6, 85-015 BYDGOSZCZ

Date of registration in KRS

2005-10-12

Date of commencement of economic activity

2005-10-12

Act signature

RDF/647457/24/188

Website

WWW.APTEKA.ZYJ-ZDROWO.COM

Pkd codes

47.73.Z - Dispensing chemist in specialised stores

21.10.Z - Manufacture of basic pharmaceutical substances

21.20.Z - Manufacture of medicines and other pharmaceutical products

32.50.Z - Manufacture of medical and dental instruments and supplies

43.3 - Building completion and finishing

47.74.Z - Retail sale of medical and orthopaedic goods in specialised stores

47.75.Z - Retail sale of cosmetic and toilet articles in specialised stores

49.41.Z - Freight transport by road

68.20.Z - Rental and operating of own or leased real estate

86.23.Z - Dental practice activities


Active
Vat list bank account(s)

Company authorities

representation authorityREPRESENTING THE COMPANY PARTNERS
representation type
SAMOISTNA
REPRESENTING THE COMPANY PARTNERS
Anna Barbara Miller
57 years old
shareholders
Anna Barbara Miller
Monika Anna Miller Burchacka

EU grants

Financial data

Net sales [PLN]
Gross profit / loss [PLN]
Automatically generated based on financial statements from KRS Registry
2021 2022 2023
M PLN
M PLN
M PLN
%
Gross profit (loss) Indicator description
0,4
0,3
0,5
65,3
EBITDA Indicator description
0,4
0,3
0,5
48,4
Short time liabilities Indicator description
0,9
1
1
2,3
Equity capital Indicator description
1,3
1,2
1,4
15,6
Operating profit (EBIT) Indicator description
0,4
0,3
0,5
65,6
Assets Indicator description
2,3
2,3
2,4
7,6
Net profit (loss) Indicator description
0,4
0,3
0,5
65,3
Cash Indicator description
0,2
0,3
0,3
-16,3
Net income from sale Indicator description
6,5
7,8
9,7
23,7
Liabilities and provisions for liabilities Indicator description
1
1,1
1,1
-1,3
Working assets Indicator description
2,2
2,2
2,3
8,6
Depreciation Indicator description
0
0
0
-64,5
%
%
%
p.p.
Profitability of capital Indicator description
31,5
23,8
34,1
10,3
Equity capital to total assets Indicator description
56,9
52,9
56,8
3,9
Gross profit margin Indicator description
6,4
3,6
4,8
1,2
EBITDA Margin Indicator description
6,9
4,2
5
0,8
Days
Days
Days
Days
Short term commitment turnover cycle Indicator description
49
47
39
-8
Current financial liquidity indicator Indicator description
2.5057213306427
2.115189790725708
2.2303452491760254
0,1
Net dept to EBITDA Indicator description
-0.22762256860733032
-0.9001458883285522
-0.5849375128746033
0,3
See more

Financial statements

01-01-2023 - 31-12-2023
Annual financial report
Download xml

01-01-2023 - 31-12-2023
Annual financial report
Download pdf

01-01-2023 - 31-12-2023
Annual financial report
Download pdf
uses security  reCAPTCHA

Opinions

Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane

0/ 5.0
How do you rate this company?
Your opinion matters to us.

Companies registered in the same sector